Literature DB >> 11077505

[Treatment of esophageal varices with banding ligation].

E Brenna1, B Flaaten, H L Waldum, H E Myrvold.   

Abstract

BACKGROUND: Randomised trials have shown that banding ligation is superior to sclerotherapy, requiring fewer treatment sessions to achieve variceal eradication, and giving lower rebleeding and complication rates.
MATERIAL AND METHODS: From November 1997 through December 1999, we have treated 22 patients with bleeding oesophageal varices with endoscopic banding ligation to obliterate the varices and prevent recurrent bleeding.
RESULTS: A total of 72 banding procedures have been performed using rubber bands. The varices have been obliterated in 14 patients requiring a median of 3.5 (range 2-8) procedures, which is in good agreement with other published data. Twelve of these patients have been observed for a median of six (range 1-19) months without signs of recurrent bleeding. One patient had a bleeding four months after the last ligation procedure; the varices were obliterated six weeks before. One patient had a recurrent bleeding between the first and second banding procedure. One patient bled from an oesophageal ulcer caused by a rubber band two weeks after the procedure. Otherwise no serious complications occurred.
INTERPRETATION: On the basis of our own experiences and published studies, we propose that endoscopic banding ligation should be the method of choice for elective treatment of bleeding varices.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077505

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Endoscopic measurement of variceal diameter.

Authors:  Zhi-Qun Li; En-Qiang Linghu; Min Hu; Xiang-Dong Wang; Hong-Bin Wang; Jing-Yun Meng; Hong Du
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

2.  Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension.

Authors:  Rui-Yun Xu; Bo Liu; Nan Lin
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.